International Brazilian Journal of Urology (Sep 2023)

Long-term oncological and surgical outcomes after Video Endoscopic Inguinal Lymphadenectomy (VEIL) in patients with penile cancer

  • Marcos Tobias-Machado,
  • Antonio A. Ornellas,
  • Alexandre K. Hidaka,
  • Luis G. Medina,
  • Pablo A. L. Mattos,
  • Ruben S. Besio,
  • Diego Abreu,
  • Pedro R. Castro,
  • Ricardo H. Nishimoto,
  • Juan Astigueta,
  • Aurus Dourado,
  • Roberto D. Machado,
  • Wesley J. Magnabosco,
  • Victor Corona-Montes,
  • Gustavo M. Villoldo,
  • Hamilton C. Zampolli,
  • Anis Taha,
  • Pericles R. Auad,
  • Eliney F. Faria,
  • Paulo B. O. Arantes,
  • Alessandro Tavares,
  • Francisco S. M. S. Nascimento,
  • Eder S. Brazão Jr.,
  • Maurício M. Rocha,
  • Walter H. Costa,
  • Vinicius Panico,
  • Leonardo O. Reis,
  • Roberto J. Almeida-Carrera,
  • Rafael C. Silva,
  • Stênio C. Zequi,
  • José R. R. Calixto,
  • Rene Sotelo

DOI
https://doi.org/10.1590/s1677-5538.ibju.2023.0065
Journal volume & issue
Vol. 49, no. 5
pp. 580 – 589

Abstract

Read online

ABSTRACT Objective: To report outcomes from the largest multicenter series of penile cancer patients undergoing video endoscopic inguinal lymphadenectomy (VEIL). Materials and Methods: Retrospective multicenter analysis. Authors of 21 centers from the Penile Cancer Collaborative Coalition-Latin America (PeC-LA) were included. All centers performed the procedure following the same previously described standardized technique. Inclusion criteria included penile cancer patients with no palpable lymph nodes and intermediate/high-risk disease and those with non-fixed palpable lymph nodes less than 4 cm in diameter. Categorical variables are shown as percentages and frequencies whereas continuous variables as mean and range. Results: From 2006 to 2020, 210 VEIL procedures were performed in 105 patients. Mean age was 58 (45-68) years old. Mean operative time was 90 minutes (60-120). Mean lymph node yield was 10 nodes (6-16). Complication rate was 15.7%, including severe complications in 1.9% of procedures. Lymphatic and skin complications were noted in 8.6 and 4.8% of patients, respectively. Histopathological analysis revealed lymph node involvement in 26.7% of patients with non-palpable nodes. Inguinal recurrence was observed in 2.8% of patients. 10y- overall survival was 74.2% and 10-y cancer specific survival was 84.8%. CSS for pN0, pN1, pN2 and pN3 were 100%, 82.4%, 72.7% and 9.1%, respectively. Conclusion: VEIL seems to offer appropriate long term oncological control with minimal morbidity. In the absence of non-invasive stratification measures such as dynamic sentinel node biopsy, VEIL emerged as the alternative for the management of non-bulky lymph nodes in penile cancer.

Keywords